Paper32551978
Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N and 2 others. Drug Deliv, 2020. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Papers, record 32551978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32551978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Intraocular Pressure | Major topic |
| Liposomes | Major topic |
| Pilocarpine | Major topic |
| Administration, Ophthalmic | |
| Animals | |
| Chemistry, Pharmaceutical | |
| Drug Liberation | |
| Drug Stability | |
| Glaucoma | |
| Hexoses | |
| Particle Size | |
| Rabbits |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12062505 | Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. | Int J Pharm | 2002 | https://conductscience.org/library/papers/12062505 | PubMed |
| 2 | 25356469 | 1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987. | J Control Release | 2014 | https://conductscience.org/library/papers/25356469 | PubMed |
| 3 | 10697760 | Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. | Drug Dev Ind Pharm | 2000 | https://conductscience.org/library/papers/10697760 | PubMed |
| 4 | 15120486 | The inflow and outflow of anti-glaucoma drugs. | Trends Pharmacol Sci | 2004 | https://conductscience.org/library/papers/15120486 | PubMed |
| 5 | 11719010 | Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. | Int J Pharm | 2002 | https://conductscience.org/library/papers/11719010 | PubMed |
| 6 | 19780133 | Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. | J Pharm Sci | 2010 | https://conductscience.org/library/papers/19780133 | PubMed |
| 7 | 27293976 | In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin. | Scientifica (Cairo) | 2016 | https://conductscience.org/library/papers/27293976 | PubMed |
| 8 | 23131800 | In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. | Eur J Pharm Sci | 2013 | https://conductscience.org/library/papers/23131800 | PubMed |
| 9 | 16290741 | Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. | J Colloid Interface Sci | 2002 | https://conductscience.org/library/papers/16290741 | PubMed |
| 10 | 15021223 | Current management of glaucoma. | Curr Opin Ophthalmol | 2004 | https://conductscience.org/library/papers/15021223 | PubMed |
| 11 | 24672401 | Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. | ScientificWorldJournal | 2014 | https://conductscience.org/library/papers/24672401 | PubMed |
| 12 | 16198021 | The use of mucoadhesive polymers in ocular drug delivery. | Adv Drug Deliv Rev | 2005 | https://conductscience.org/library/papers/16198021 | PubMed |
| 13 | 11297896 | Modeling and comparison of dissolution profiles. | Eur J Pharm Sci | 2001 | https://conductscience.org/library/papers/11297896 | PubMed |
| 14 | 23104306 | Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. | AAPS PharmSciTech | 2012 | https://conductscience.org/library/papers/23104306 | PubMed |
| 15 | 27091293 | Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. | Int J Pharm | 2016 | https://conductscience.org/library/papers/27091293 | PubMed |
| 16 | 12852427 | Introduction: three targets for glaucoma management. | Surv Ophthalmol | 2003 | https://conductscience.org/library/papers/12852427 | PubMed |
| 17 | 10425362 | Proniosomes: a novel drug carrier preparation. | Int J Pharm | 1999 | https://conductscience.org/library/papers/10425362 | PubMed |
| 18 | 9742041 | Discoidal niosome based controlled ocular delivery of timolol maleate. | Pharmazie | 1998 | https://conductscience.org/library/papers/9742041 | PubMed |
| 19 | 15158634 | Primary open-angle glaucoma. | Lancet | 2004 | https://conductscience.org/library/papers/15158634 | PubMed |
| 20 | 311169 | Experimental corticosteroid ocular hypertension in the rabbit. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1978 | https://conductscience.org/library/papers/311169 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769214 | Mannitol plus pilocarpine for primary acute angle-closure glaucoma: efficacy and safety analysis. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769214 | PubMed |
| 40702295 | Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/40702295 | PubMed |
| 40284442 | Topical Ocular Drug Delivery: The Impact of Permeation Enhancers. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284442 | PubMed |
| 39697473 | Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections. | Saudi Pharm J | 2024 | https://conductscience.org/library/papers/39697473 | PubMed |
| 38380035 | Langmuir monolayer studies of non-ionic surfactants and DOTMA for the design of ophthalmic niosomes. | Heliyon | 2024 | https://conductscience.org/library/papers/38380035 | PubMed |
| 38254071 | Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38254071 | PubMed |
| 38158475 | Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment. | Daru | 2024 | https://conductscience.org/library/papers/38158475 | PubMed |
| 37587812 | Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug. | Pharm Nanotechnol | 2024 | https://conductscience.org/library/papers/37587812 | PubMed |
| 37299085 | Potential Distribution of Pilocarpus microphyllus in the Amazonia/Cerrado Biomes under Near-Future Climate Change Scenarios. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37299085 | PubMed |
| 36987154 | Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/36987154 | PubMed |
| 36826309 | Preparation and Characterization of Silymarin Gel: A Novel Topical Mucoadhesive Formulation for Potential Applicability in Oral Pathologies. | Gels | 2023 | https://conductscience.org/library/papers/36826309 | PubMed |
| 35494641 | Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds. | Front Chem | 2022 | https://conductscience.org/library/papers/35494641 | PubMed |
| 35277107 | Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35277107 | PubMed |
| 35235173 | In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/35235173 | PubMed |
| 35174743 | Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35174743 | PubMed |
| 34218424 | The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye. | Ophthalmol Ther | 2021 | https://conductscience.org/library/papers/34218424 | PubMed |
| 34208623 | Concise Synthesis of Both Enantiomers of Pilocarpine. | Molecules | 2021 | https://conductscience.org/library/papers/34208623 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32551978
GET https://conductscience.org/api/papers/v1/32551978/references?page=2